Stay updated on Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial

Sign up to get notified when there's something new on the Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A centralized Locations section now lists District of Columbia, Florida, New Jersey, and New York as study sites, replacing separate location subsections and removing the HHS Vulnerability Disclosure link.
    Difference
    0.5%
    Check dated 2025-12-23T21:15:18.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2; no study content or eligibility details were affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:59:49.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The government funding notice banner on the page has been removed. The study details and navigation remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T07:00:11.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Results-related information has been added to the Study Record Dates, including a newly posted results entry dated 2024-04-04 and related QC updates. The page now reflects posted results and completed study record updates.
    Difference
    0.4%
    Check dated 2025-11-03T21:08:08.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.
    Difference
    4%
    Check dated 2025-10-06T05:50:52.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes provided.
    Difference
    0.1%
    Check dated 2025-09-29T03:11:32.000Z thumbnail image

Stay in the know with updates to Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Biomarker Study in Melanoma: Nivolumab + Ipilimumab Clinical Trial page.